Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 614

1.

Crosstalk between Vaginal Microbiome and Female Health: A review.

Gupta S, Kakkar V, Bhushan I.

Microb Pathog. 2019 Nov;136:103696. doi: 10.1016/j.micpath.2019.103696. Epub 2019 Aug 23. Review.

PMID:
31449855
2.

DARPin based GMR Biosensor for the detection of ESAT-6 Tuberculosis Protein.

Gupta S, Kakkar V.

Tuberculosis (Edinb). 2019 Sep;118:101852. doi: 10.1016/j.tube.2019.07.003. Epub 2019 Jul 20.

PMID:
31430697
3.

Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature.

Kakkar V, Verma MK, Saini K, Kaur IP.

Curr Drug Targets. 2019;20(10):1008-1017. doi: 10.2174/1389450120666190319125734.

PMID:
30892161
4.

Formulation and Evaluation of Silymarin-Loaded Chitosan-Montmorilloite Microbeads for the Potential Treatment of Gastric Ulcers.

Sharma A, Puri V, Kakkar V, Singh I.

J Funct Biomater. 2018 Sep 10;9(3). pii: E52. doi: 10.3390/jfb9030052.

5.

Inverse association of ApoB and HSP60 antibodies with coronary artery disease in Indian population.

Ponnusamy T, Venkatachala SK, Ramanjappa M, Kakkar VV, Mundkur LA.

Heart Asia. 2018 Jun 26;10(2):e011018. doi: 10.1136/heartasia-2018-011018. eCollection 2018.

6.

Doing Mastoidectomy Along with Tympanic Membrane Repair Reduces the Need for Revision Procedures: A Prospective Study.

Garg S, Kakkar V.

Indian J Otolaryngol Head Neck Surg. 2018 Jun;70(2):262-266. doi: 10.1007/s12070-017-1177-3. Epub 2017 Aug 7.

7.

Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study.

Kakkar V, Kaur IP, Kaur AP, Saini K, Singh KK.

Drug Dev Ind Pharm. 2018 Oct;44(10):1701-1712. doi: 10.1080/03639045.2018.1492607. Epub 2018 Jul 25.

PMID:
29938544
8.

Recent technological advancements in tuberculosis diagnostics - A review.

Gupta S, Kakkar V.

Biosens Bioelectron. 2018 Sep 15;115:14-29. doi: 10.1016/j.bios.2018.05.017. Epub 2018 May 11. Review.

PMID:
29783081
9.

Comparative analysis of inflammatory gene expression levels in metabolic syndrome & coronary artery disease.

Nair J, Kakkar VV, Shanker J.

Indian J Med Res. 2017 Jun;145(6):777-785. doi: 10.4103/ijmr.IJMR_1678_14.

10.

Danger-recognizing proteins, β-defensin-128 and histatin-3, as potential biomarkers of recurrent coronary events.

Ghatge M, Sharma A, Maity S, Kakkar VV, Vangala RK.

Int J Mol Med. 2017 Aug;40(2):531-538. doi: 10.3892/ijmm.2017.3031. Epub 2017 Jun 19.

PMID:
28627688
11.

Versatile members of the DNAJ family show Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G.

Kakkar V, Kuiper EF, Pandey A, Braakman I, Kampinga HH.

Sci Rep. 2016 Oct 7;6:34830. doi: 10.1038/srep34830.

12.

Sesamol Induces Apoptosis by Altering Expression of Bcl-2 and Bax Proteins and Modifies Skin Tumor Development in Balb/c Mice.

Bhardwaj R, Sanyal SN, Vaiphei K, Kakkar V, Deol PK, Kaur IP, Kaur T.

Anticancer Agents Med Chem. 2017;17(5):726-733. doi: 10.2174/1871520616666160819103249.

PMID:
27539478
13.

Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.

Deshpande V, Krishnan R, Philip S, Faludi I, Ponnusamy T, Thota LN, Endresz V, Lu X, Kakkar VV, Mundkur LA.

Cardiovasc Ther. 2016 Oct;34(5):314-24. doi: 10.1111/1755-5922.12201.

PMID:
27241889
14.

The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse Model.

Kakkar V, Månsson C, de Mattos EP, Bergink S, van der Zwaag M, van Waarde MAWH, Kloosterhuis NJ, Melki R, van Cruchten RTP, Al-Karadaghi S, Arosio P, Dobson CM, Knowles TPJ, Bates GP, van Deursen JM, Linse S, van de Sluis B, Emanuelsson C, Kampinga HH.

Mol Cell. 2016 Apr 21;62(2):272-283. doi: 10.1016/j.molcel.2016.03.017. Epub 2016 Apr 14.

15.

Understanding the progression of atherosclerosis through gene profiling and co-expression network analysis in Apob(tm2Sgy)Ldlr(tm1Her) double knockout mice.

Deshpande V, Sharma A, Mukhopadhyay R, Thota LN, Ghatge M, Vangala RK, Kakkar VV, Mundkur L.

Genomics. 2016 Jun;107(6):239-47. doi: 10.1016/j.ygeno.2016.04.007. Epub 2016 Apr 28.

16.

Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits.

Philip S, Ponnusamy T, Rao LN, Biradar S, Kumar R, Deshpande V, Lu X, Kakkar VV, Mundkur LA.

Can J Cardiol. 2016 Aug;32(8):1008.e1-1008.e10. doi: 10.1016/j.cjca.2015.09.022. Epub 2015 Oct 22.

PMID:
27062234
17.

Contribution of classical and emerging risk factors to coronary artery disease in Asian Indians.

Shanker J, Kakkar VV.

Int J Cardiol. 2016 Jul 1;214:97-106. doi: 10.1016/j.ijcard.2016.03.012. Epub 2016 Mar 25.

PMID:
27060267
18.
19.

Essential Roles of Toll-Like Receptors in Atherosclerosis.

Lin J, Kakkar V, Lu X.

Curr Med Chem. 2016;23(5):431-54. Review.

PMID:
26639096
20.

The augmented anticancer potential of AP9-cd loaded solid lipid nanoparticles in human leukemia Molt-4 cells and experimental tumor.

Bhushan S, Kakkar V, Pal HC, Mondhe DM, Kaur IP.

Chem Biol Interact. 2016 Jan 25;244:84-93. doi: 10.1016/j.cbi.2015.11.022. Epub 2015 Nov 24.

PMID:
26620693
21.

The role of interleukin 35 in atherosclerosis.

Lin J, Kakkar V, Lu X.

Curr Pharm Des. 2015;21(35):5151-9. Review.

PMID:
26530251
22.

The role of interleukin 35 in atherosclerosis.

Lin J, Kakkar V, Lu X.

Curr Pharm Des. 2015 Sep 15. [Epub ahead of print]

PMID:
26369677
23.

Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.

Rao LN, Ponnusamy T, Philip S, Mukhopadhyay R, Kakkar VV, Mundkur L.

Lipids. 2015 Aug;50(8):785-97. doi: 10.1007/s11745-015-4046-4. Epub 2015 Jul 16.

PMID:
26178198
24.

Sesamol loaded solid lipid nanoparticles: a promising intervention for control of carbon tetrachloride induced hepatotoxicity.

Singh N, Khullar N, Kakkar V, Kaur IP.

BMC Complement Altern Med. 2015 May 3;15:142. doi: 10.1186/s12906-015-0655-y.

25.

Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice.

Xia M, Chen D, Endresz V, Lantos I, Szabo A, Kakkar V, Lu X.

PLoS One. 2015 Apr 1;10(4):e0123393. doi: 10.1371/journal.pone.0123393. eCollection 2015.

26.

Expression of human tissue factor pathway inhibitor on vascular smooth muscle cells inhibits secretion of macrophage migration inhibitory factor and attenuates atherosclerosis in ApoE-/- mice.

Chen D, Xia M, Hayford C, Tham el-L, Semik V, Hurst S, Chen Y, Tam HH, Pan J, Wang Y, Tan X, Lan HY, Shen H, Kakkar VV, Xu Q, McVey JH, Dorling A.

Circulation. 2015 Apr 14;131(15):1350-60. doi: 10.1161/CIRCULATIONAHA.114.013423. Epub 2015 Feb 12.

PMID:
25677604
27.

Hepatoprotective effects of sesamol loaded solid lipid nanoparticles in carbon tetrachloride induced sub-chronic hepatotoxicity in rats.

Singh N, Khullar N, Kakkar V, Kaur IP.

Environ Toxicol. 2016 May;31(5):520-32. doi: 10.1002/tox.22064. Epub 2014 Nov 20.

PMID:
25410024
28.

Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer.

Geetha T, Kapila M, Prakash O, Deol PK, Kakkar V, Kaur IP.

J Drug Target. 2015 Feb;23(2):159-69. doi: 10.3109/1061186X.2014.965717. Epub 2014 Sep 30.

PMID:
25268273
29.

Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice.

Mundkur L, Ponnusamy T, Philip S, Rao LN, Biradar S, Deshpande V, Kumar R, Lu X, Kakkar VV.

Int J Cardiol. 2014 Aug 1;175(2):340-51. doi: 10.1016/j.ijcard.2014.06.001. Epub 2014 Jun 10.

PMID:
24962340
30.

Issues and concerns in nanotech product development and its commercialization.

Kaur IP, Kakkar V, Deol PK, Yadav M, Singh M, Sharma I.

J Control Release. 2014 Nov 10;193:51-62. doi: 10.1016/j.jconrel.2014.06.005. Epub 2014 Jun 14. Review.

PMID:
24933600
31.

Impact of MCP-1 in atherosclerosis.

Lin J, Kakkar V, Lu X.

Curr Pharm Des. 2014;20(28):4580-8. Review.

PMID:
24862889
32.

Network analysis of inflammatory genes and their transcriptional regulators in coronary artery disease.

Nair J, Ghatge M, Kakkar VV, Shanker J.

PLoS One. 2014 Apr 15;9(4):e94328. doi: 10.1371/journal.pone.0094328. eCollection 2014.

33.

Barcoding heat shock proteins to human diseases: looking beyond the heat shock response.

Kakkar V, Meister-Broekema M, Minoia M, Carra S, Kampinga HH.

Dis Model Mech. 2014 Apr;7(4):421-34. doi: 10.1242/dmm.014563. Review.

34.

The Copper Metabolism MURR1 domain protein 1 (COMMD1) modulates the aggregation of misfolded protein species in a client-specific manner.

Vonk WI, Kakkar V, Bartuzi P, Jaarsma D, Berger R, Hofker MH, Klomp LW, Wijmenga C, Kampinga HH, van de Sluis B.

PLoS One. 2014 Apr 1;9(4):e92408. doi: 10.1371/journal.pone.0092408. eCollection 2014.

35.

CELSR2-PSRC1-SORT1 gene expression and association with coronary artery disease and plasma lipid levels in an Asian Indian cohort.

Arvind P, Nair J, Jambunathan S, Kakkar VV, Shanker J.

J Cardiol. 2014 Nov;64(5):339-46. doi: 10.1016/j.jjcc.2014.02.012. Epub 2014 Mar 24.

36.

Attenuation of carbon tetrachloride-induced hepatic injury with curcumin-loaded solid lipid nanoparticles.

Singh N, Khullar N, Kakkar V, Kaur IP.

BioDrugs. 2014 Jun;28(3):297-312. doi: 10.1007/s40259-014-0086-1.

PMID:
24567262
37.

Impact of matrix metalloproteinases on atherosclerosis.

Lin J, Kakkar V, Lu X.

Curr Drug Targets. 2014 Apr;15(4):442-53. Review.

PMID:
24517161
38.

Genetic analysis of the 9p21.3 CAD risk locus in Asian Indians.

Shanker J, Arvind P, Jambunathan S, Nair J, Kakkar V.

Thromb Haemost. 2014 May 5;111(5):960-9. doi: 10.1160/TH13-08-0706. Epub 2014 Jan 23.

PMID:
24452806
39.

Expression analysis of leukotriene-inflammatory gene interaction network in patients with coronary artery disease.

Nair J, Shanker J, Jambunathan S, Arvind P, Kakkar VV.

J Atheroscler Thromb. 2014;21(4):329-45. Epub 2013 Dec 20.

40.

The roles of microRNAs in atherosclerosis.

Lu X, Kakkar V.

Curr Med Chem. 2014;21(13):1531-43. Review.

PMID:
24350842
41.

Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.

Xia M, Chen D, Endresz V, Faludi I, Szabo A, Gonczol E, Kakkar V, Lu X.

PLoS One. 2013 Dec 13;8(12):e81056. doi: 10.1371/journal.pone.0081056. eCollection 2013. Erratum in: PLoS One. 2014;9(5):e99474.

42.

Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood.

Kumar M, Kakkar V, Mishra AK, Chuttani K, Kaur IP.

Int J Pharm. 2014 Jan 30;461(1-2):223-33. doi: 10.1016/j.ijpharm.2013.11.038. Epub 2013 Nov 25.

PMID:
24286922
43.

Inflammasome and atherogenesis.

Lu X, Kakkar V.

Curr Pharm Des. 2014;20(1):108-24. Review.

PMID:
23944376
44.

DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios.

Månsson C, Kakkar V, Monsellier E, Sourigues Y, Härmark J, Kampinga HH, Melki R, Emanuelsson C.

Cell Stress Chaperones. 2014 Mar;19(2):227-39. doi: 10.1007/s12192-013-0448-5. Epub 2013 Aug 1.

45.

Relationship between periodontal disease, Porphyromonas gingivalis, peripheral vascular resistance markers and coronary artery disease in Asian Indians.

Shanker J, Setty P, Arvind P, Nair J, Bhasker D, Balakrishna G, Kakkar VV.

Thromb Res. 2013 Jul;132(1):e8-14. doi: 10.1016/j.thromres.2013.04.023. Epub 2013 May 21.

PMID:
23706960
46.

Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain.

Kakkar V, Mishra AK, Chuttani K, Kaur IP.

Int J Pharm. 2013 May 20;448(2):354-9. doi: 10.1016/j.ijpharm.2013.03.046. Epub 2013 Apr 1.

PMID:
23558314
47.

Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.

Mundkur L, Mukhopadhyay R, Samson S, Varma M, Kale D, Chen D, Shivaprasad S, Sivanandan H, Soman V, Lu X, Kakkar VV.

PLoS One. 2013;8(3):e58364. doi: 10.1371/journal.pone.0058364. Epub 2013 Mar 11.

48.

Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.

Kakkar V, Muppu SK, Chopra K, Kaur IP.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):339-45. doi: 10.1016/j.ejpb.2013.02.005. Epub 2013 Feb 27.

PMID:
23454202
49.

Activation of inflammatory cells and cytokines by peptide epitopes in vitro: a simple in-vitro screening assay for prioritizing them for in-vivo studies.

Mundkur LA, Varma M, Shivanandan H, Krishna D, Kumar K, Lu X, Kakkar VV.

Inflamm Res. 2013 May;62(5):471-81. doi: 10.1007/s00011-013-0599-y. Epub 2013 Feb 12.

PMID:
23400302
50.

DNAJ proteins and protein aggregation diseases.

Kakkar V, Prins LC, Kampinga HH.

Curr Top Med Chem. 2012;12(22):2479-90. Review.

PMID:
23339302

Supplemental Content

Loading ...
Support Center